5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers.
Saved in:
| Title: | 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers. |
|---|---|
| Authors: | Hosmann A; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center-Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, 1090 Vienna, Austria., Millesi M; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center-Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, 1090 Vienna, Austria., Wadiura LI; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center-Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, 1090 Vienna, Austria., Kiesel B; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center-Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, 1090 Vienna, Austria., Mercea PA; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center-Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, 1090 Vienna, Austria., Mischkulnig M; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center-Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, 1090 Vienna, Austria., Borkovec M; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria., Furtner J; Division of Neuroradiology and Musculoskeletal Radiology, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090 Vienna, Austria., Roetzer T; Comprehensive Cancer Center-Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, 1090 Vienna, Austria.; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria., Wolfsberger S; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center-Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, 1090 Vienna, Austria., Phillips JJ; Department of Pathology, University of California, San Francisco (UCSF), CA 94143, USA., Berghoff AS; Comprehensive Cancer Center-Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, 1090 Vienna, Austria.; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria., Hervey-Jumper S; Department of Neurological Surgery, University of California, San Francisco (UCSF), CA 94143, USA., Berger MS; Department of Neurological Surgery, University of California, San Francisco (UCSF), CA 94143, USA., Widhalm G; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center-Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, 1090 Vienna, Austria. |
| Source: | Cancers [Cancers (Basel)] 2021 May 21; Vol. 13 (11). Date of Electronic Publication: 2021 May 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
